Document

brochure sur les produits et services medchemexpress

présentation des inhibiteurs, agonistes et bibliothèques de criblage

Contenu du document

medchemexpress

Inhibitors & Agonists
25,000+ Specific Inhibitors & Agonists Targeting 20+ Classic Signaling Pathways.

Compound Screening Libraries: 50+ Compound Screening Libraries Optimized for Disease Mechanism Revealing & Drug Repurposing.

Publications Citing Use of MCE Products

Several high-impact journals, including Nature and Science, have cited MCE products in recent publications.

Product Offerings

25,000+ selective inhibitors and agonists targeting 375 key proteins in 20+ signaling pathways.
10,000+ small molecules with validated biological and pharmacological activities.

Quality Control & Innovation

Robust quality control methods assure high product quality and purity.
Access to the latest scientific innovations and newest compounds.

Scientific Validation & Partnerships

Products' biological activities are validated by worldwide customers and published in top scientific journals.
Collaboration with renowned research institutes and pharmaceutical companies.

Signaling Pathways: PI3K/Akt/mTOR, Epigenetics, Autophagy, Apoptosis, Cell Cycle/DNA Damage, Metabolic Enzyme/Protease, Protein Tyrosine Kinase/RTK, Immunology/Inflammation, Stem Cell/Wnt, Anti-infection, JAK/STAT Signaling, MAPK/ERK Pathway, GPCR/G Protein, Neuronal Signaling, Membrane Transporter/Ion Channel, Cytoskeleton, NF-?B, TGF-beta/Smad, VD/VDR, Antibody-drug Conjugate/ADC Related, PROTAC.

Compound Screening Libraries & Virtual Screening

Over 10,000 small molecules are available for high-throughput screening (HTS) and high-content screening (HCS). Virtual screening offers tools for drug discovery. Databases and compounds are provided by Enamine, LifeChemicals, Specs, and Chemspace.

Our Key Partners

Collaborations with institutions like the National Institutes of Health and Massachusetts Institute of Technology.

For more information, visit www.MedChemExpress.com